Volf, Eva M <br/><br/>
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.  [electronic resource] 

 -  Journal of drugs in dermatology : JDD  Mar 2012 
 - 341-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1545-9616 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Dermatitis, Allergic Contact--drug therapy<br/>Dermatitis, Atopic--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Phosphodiesterase 4 Inhibitors--administration & dosage<br/>Severity of Illness Index<br/>Thalidomide--adverse effects<br/>Treatment Outcome<br/>Young Adult